| Critical Path Institute’s Transplant Therapeutics Consortium | |
| Government and Regulatory Agencies | |
| • National Institutes of Health | |
| • U.S. Food and Drug Administration | |
| Academic Institutions | |
| • Charité – Universitätsmedizin Berlin | |
| • Helsinki University Hospital | |
| • Hospital do Rim | |
| • Houston Methodist Hospital | |
| • Katholieke Universiteit Leuven | |
| • Mayo Clinic | |
| • Necker Hospital, Paris Transplant Group | |
| • University of Colorado, Denver | |
| • University of Wisconsin, School of Medicine | |
| • University of Manitoba | |
| Professional Societies | |
| • American Society of Transplantation | |
| • American Society of Transplant Surgeons | |
| • The European Society for Organ Transplantation | |
| • The Transplantation Society | |
| Biopharmaceutical Industry and Diagnostic Companies | |
| • argenx | |
| • Bristol Myers Squibb | |
| • CareDx | |
| • CSL Behring | |
| • Eledon Pharmaceuticals | |
| • Eurofins Transplant Genomics | |
| • Hansa Biopharma | |
| • Immucor | |
| • Novartis | |
| • Sanofi | |
| • Takeda Pharmaceutical Company Limited | |
| • Talaris Therapeutics | |
| • Thermo Fisher Scientific Incorporated | |
| • Veloxis Pharmaceuticals | |
| Additional Acknowledgments: | |
| • Anat Tambur | • Klaus Romero |
| • Byron Smith | • Lauren Quinlan |
| • Cecile Olivier | • Mark Haas |
| • Christina Higgins | • Mike Pauley |
| • Christine Miller | • Nicholas King |
| • Devrim Eren | • Nicole Spear |
| • Erin Beach | • Patrick Lang |
| • Grace Erhart | • Rhoda Muse |
| • Hailey Davenport | • Sarah David |
| • Howie Gebel | • Stephen Karpen |
| • Jackson Burton | • Stephen Piccoli |
| • John Holman | • Zihan Cui |
| • Kitty Bogy | |